BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17050039)

  • 1. A quantitative regional expression profile of EAAT2 known and novel splice variants reopens the question of aberrant EAAT2 splicing in disease.
    Lauriat TL; Richler E; McInnes LA
    Neurochem Int; 2007 Jan; 50(1):271-80. PubMed ID: 17050039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The concentrations and distributions of three C-terminal variants of the GLT1 (EAAT2; slc1a2) glutamate transporter protein in rat brain tissue suggest differential regulation.
    Holmseth S; Scott HA; Real K; Lehre KP; Leergaard TB; Bjaalie JG; Danbolt NC
    Neuroscience; 2009 Sep; 162(4):1055-71. PubMed ID: 19328838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of 5' splice variants of the glutamate transporter EAAT2 in an in vivo model of chemical hypoxia induced by 3-nitropropionic acid.
    Münch C; Zhu BG; Leven A; Stamm S; Einkörn H; Schwalenstöcker B; Ludolph AC; Riepe MW; Meyer T
    J Neurosci Res; 2003 Mar; 71(6):819-25. PubMed ID: 12605408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing of glutamate transporter EAAT2 RNA in neocortex and hippocampus of temporal lobe epilepsy patients.
    Hoogland G; van Oort RJ; Proper EA; Jansen GH; van Rijen PC; van Veelen CW; van Nieuwenhuizen O; Troost D; de Graan PN
    Epilepsy Res; 2004; 59(2-3):75-82. PubMed ID: 15246112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
    Romera C; Hurtado O; Mallolas J; Pereira MP; Morales JR; Romera A; Serena J; Vivancos J; Nombela F; Lorenzo P; Lizasoain I; Moro MA
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1327-38. PubMed ID: 17213861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis.
    Flowers JM; Powell JF; Leigh PN; Andersen P; Shaw CE
    Ann Neurol; 2001 May; 49(5):643-9. PubMed ID: 11357955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple 5'-splice variants of the rat glutamate transporter-1.
    Rozyczka J; Engele J
    Brain Res Mol Brain Res; 2005 Jan; 133(1):157-61. PubMed ID: 15661376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the exon 9-skipping form of EAAT2 in astrocytes of rats.
    Macnab LT; Pow DV
    Neuroscience; 2007 Dec; 150(3):705-11. PubMed ID: 17981401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative splicing of the 5'-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis.
    Münch C; Ebstein M; Seefried U; Zhu B; Stamm S; Landwehrmeyer GB; Ludolph AC; Schwalenstöcker B; Meyer T
    J Neurochem; 2002 Aug; 82(3):594-603. PubMed ID: 12153483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of multiple exon-skipping mRNA splice variants using SYBR Green real-time RT-PCR.
    Walton HS; Gebhardt FM; Innes DJ; Dodd PR
    J Neurosci Methods; 2007 Mar; 160(2):294-301. PubMed ID: 17097739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel splice variants of human ADAR2 mRNA: skipping of the exon encoding the dsRNA-binding domains, and multiple C-terminal splice sites.
    Kawahara Y; Ito K; Ito M; Tsuji S; Kwak S
    Gene; 2005 Dec; 363():193-201. PubMed ID: 16297572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splice variants of the glutamate transporter GLT1 form hetero-oligomers that interact with PSD-95 and NMDA receptors.
    González-González IM; García-Tardón N; Giménez C; Zafra F
    J Neurochem; 2009 Jul; 110(1):264-74. PubMed ID: 19457061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of the glutamate transporter EAAT2b in neurological disease.
    Maragakis NJ; Dykes-Hoberg M; Rothstein JD
    Ann Neurol; 2004 Apr; 55(4):469-77. PubMed ID: 15048885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon 4-skipping GLT-1: a new form of an abundantly expressed glutamate transporter.
    Lee A; Anderson AR; Stevens MG; Pow DV
    Neurosci Lett; 2011 Oct; 504(3):228-31. PubMed ID: 21964391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
    Doyle GA; Rebecca Sheng X; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
    Gene; 2007 Feb; 388(1-2):135-47. PubMed ID: 17156941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A splice variant of glutamate transporter GLT1/EAAT2 expressed in neurons: cloning and localization in rat nervous system.
    Schmitt A; Asan E; Lesch KP; Kugler P
    Neuroscience; 2002; 109(1):45-61. PubMed ID: 11784699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revised genomic structure of the human ghrelin gene and identification of novel exons, alternative splice variants and natural antisense transcripts.
    Seim I; Collet C; Herington AC; Chopin LK
    BMC Genomics; 2007 Aug; 8():298. PubMed ID: 17727735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity at the 5'-end of MEN1 transcripts.
    Khodaei-O'Brien S; Zablewska B; Fromaget M; Bylund L; Weber G; Gaudray P
    Biochem Biophys Res Commun; 2000 Sep; 276(2):508-14. PubMed ID: 11027505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A candidate chimeric mammalian mRNA transcript is derived from distinct chromosomes and is associated with nonconsensus splice junction motifs.
    Zhang C; Xie Y; Martignetti JA; Yeo TT; Massa SM; Longo FM
    DNA Cell Biol; 2003 May; 22(5):303-15. PubMed ID: 12941158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative pre-mRNA splicing in Drosophila spliceosomal assembly factor RNP-4F during development.
    Fetherson RA; Strock SB; White KN; Vaughn JC
    Gene; 2006 Apr; 371(2):234-45. PubMed ID: 16497447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.